• English
  • 旧版回顾
  • 教职工
  • 学校主页
  • 加入收藏

师资队伍

曾伟伟 特聘副教授
发布时间:2025/09/11   阅读量:

一、基本信息

曾伟伟,博士,硕士生导师,特聘副教授,博士毕业于中山大学。

长期从事生物医用材料、分子药剂学、免疫学和药物递送的研究,以第一或通讯作者(含共同)在Adv Funct Mater、Bioact MaterAdv Sci、Chem Eng J、Adv Drug Deliv Rev、BiomaterialsActa Pharm Sin B等权威期刊发表论文16篇,包括4篇ESI高被引论文,1篇封面论文,H指数18,他引1700余次。主持博后面上项目、国家资助博士后研究人员计划,以及参与国自然重点项目、面上项目等;授权中国发明专利6项;荣获博士研究生国家奖学金(两次)、中山大学汪淑钧奖学金等奖励。担任ViewExplorationTradit Med Res青年编委/学术编辑。

二、教育经历

2018.9-2023.6 中山大学 | 理学博士学位 | 博士研究生毕业(导师:梅林教授)

2014.9-2018.6 华中科技大学 | 理学学士学位 | 大学本科毕业

三、工作经历

2025.6. - 至今 中南大学 | 湘雅药学院 | 特聘副教授

2023.7-2025.6 华南理工大学 | 生物医学科学与工程学院 | 助理研究员/博士后(合作导师:王均教授)

四、学术兼职

担任View、Exploration和Tradit Med Res青年编委/学术编辑

五、部分科研项目

1.主持|中国博士后科学基金面上项目, 2024.01-2025.06,8万元,已结题

2.参与|国家自然科学基金委员会重点项目, 2025.01-2029.12,218万元,在研

3.参与|国家自然科学基金委员会面上项目, 2021.01-2024.12,62万元,已结题

六、部分研究成果

1.1.J. Li, H. Wu, H. Li, Y. Zhang, H. Zhang, T. Li, W. Zeng*, D. Chen*, L. Mei*, Hemoglobin nanocatalyst with tunable autoxidation activity for tumor apoptosis-ferroptosis combination therapy. Acta Pharmaceutica Sinica B 2025.

2.H. Li, Y. Li, L. Su, K. Zheng, Y. Zhang, J. Li, F. Lv, M. Huang, T. Chen, H. Zhang, Z. Shi, D. Zhu, X. Dong*, W. Zeng*, L. Mei*, Enzyme-empowered “two birds with one stone” strategy for amplifying tumor apoptosis and metabolic clearance. Advanced Science 2024, 11, 2308251.

3.Y. Liu, Y. Yi, S. Sun, T. Wang, J. Tang, Z. Peng, W. Huang, W. Zeng*, M. Wu*, Biodegradable and efficient charge-migrated Z-scheme heterojunction amplifies cancer ferroptosis by blocking defensive redox system. Small 2024, 20, 2309206.

4.C. Huang, J. Tang, Y. Liu, T. Chen, J. Qi, S. Sun, H. Hao, W. Zeng*, J. Zhao*, M. Wu*, Hyperthermia-triggered NO release based on Cu-doped polypyrrole for synergistic catalytic/gas cancer therapy. Acta Biomaterialia 2023, 167, 463-472.

5.Y. Nie, W. Zhang, W. Xiao, W. Zeng*, T. Chen, W. Huang, X. Wu, Y. Kang, J. Dong, W. Luo*, X. Ji*, Novel biodegradable two-dimensional vanadene augmented photoelectro-Fenton process for cancer catalytic therapy. Biomaterials 2022, 289, 121791.

6.W. Zeng#, M. Yu#, T. Chen#, Y. Liu, Y. Yi, C. Huang, J. Tang, H. Li, M. Ou, T. Wang, M. Wu*, L. Mei*, Polypyrrole nanoenzymes as tumor microenvironment modulators to reprogram macrophage and potentiate immunotherapy. Advanced Science 2022, 9, 2201703.(ESI高被引论文)

7.W. Zeng#, H. Zhang#, X. Yuan, T. Chen, Z. Pei, X. Ji*, Two-dimensional nanomaterial-based catalytic medicine: theories, advanced catalyst and system design. Advanced Drug Delivery Reviews 2022, 184, 114241.

8.W. Zeng, X. Wu, T. Chen, S. Sun, Z. Shi, J. Liu, X. Ji, X. Zeng, J. Guan, L. Mei*, M. Wu*, Renal-clearable ultrasmall polypyrrole nanoparticles with size-regulated property for second near-infrared light-mediated photothermal therapy. Advanced Functional Materials 2021, 31, 2008362.

9.W. Zeng#, H. Zhang#, Y. Deng, A. Jiang, X. Bao, M. Guo, Z. Li, M. Wu, X. Ji*, X. Zeng*, L. Mei*, Dual-response oxygen-generating MnO2 nanoparticles with polydopamine modification for combined photothermal-photodynamic therapy. Chemical Engineering Journal 2020, 389, 124494.(ESI高被引论文)

10.T. Chen#, W. Zeng#, C. Tie, M. Yu, H. Hao, Y. Deng, Q. Li, H. Zheng, M. Wu*, L. Mei*, Engineered gold/black phosphorus nanoplatforms with reshaping tumor microenvironment for sonoactivated catalytic tumor theranostics. Bioactive Materials 2022, 10, 515-525.

七、联系方式

邮箱:225103@csu.edu.cn